Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 7,000.00
+50.00 (0.72%)
May 21, 2026, 12:20 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 320.03 billion as of May 20, 2026. Its market cap has increased by 187.19% in one year.
Market Cap
320.03B
Enterprise Value
237.91B
Revenue
2.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,000.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 320.03B, an increase of 34.10%. That is a compound annual growth rate of 1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 333.38B | 16.40% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 488.45B |
| SillaJen | 417.05B |
| Genomictree | 343.24B |
| Anterogen.Co.,Ltd. | 323.70B |
| GC Cell | 315.57B |
| BINEX | 301.60B |
| HLB Therapeutics | 278.15B |
| NeoImmuneTech | 247.66B |